190 related articles for article (PubMed ID: 21899946)
1. Nitroxoline (8-hydroxy-5-nitroquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline).
Jiang H; Taggart JE; Zhang X; Benbrook DM; Lind SE; Ding WQ
Cancer Lett; 2011 Dec; 312(1):11-7. PubMed ID: 21899946
[TBL] [Abstract][Full Text] [Related]
2. Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells.
Chan-On W; Huyen NT; Songtawee N; Suwanjang W; Prachayasittikul S; Prachayasittikul V
Drug Des Devel Ther; 2015; 9():2033-47. PubMed ID: 25897210
[TBL] [Abstract][Full Text] [Related]
3. Anticancer activity of the antibiotic clioquinol.
Ding WQ; Liu B; Vaught JL; Yamauchi H; Lind SE
Cancer Res; 2005 Apr; 65(8):3389-95. PubMed ID: 15833873
[TBL] [Abstract][Full Text] [Related]
4. Effect of 5-chloro-7-iodo-8-hydroxy-quinoline (clioquinol) on the uptake and distribution of nickel, zinc and mercury in mice.
Tjälve H; Ståhl K
Acta Pharmacol Toxicol (Copenh); 1984 Jul; 55(1):65-72. PubMed ID: 6235722
[TBL] [Abstract][Full Text] [Related]
5. Clioquinol targets zinc to lysosomes in human cancer cells.
Yu H; Zhou Y; Lind SE; Ding WQ
Biochem J; 2009 Jan; 417(1):133-9. PubMed ID: 18764784
[TBL] [Abstract][Full Text] [Related]
6. Clioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for prostate cancer.
Cater MA; Haupt Y
Biochem J; 2011 Jun; 436(2):481-91. PubMed ID: 21426304
[TBL] [Abstract][Full Text] [Related]
7. Repurposing of Nitroxoline Drug for the Prevention of Neurodegeneration.
Van Hau T; Ruankham W; Suwanjang W; Songtawee N; Wongchitrat P; Pingaew R; Prachayasittikul V; Prachayasittikul S; Phopin K
Chem Res Toxicol; 2019 Nov; 32(11):2182-2191. PubMed ID: 31638783
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity of clioquinol and nitroxoline: a scoping review.
Wykowski R; Fuentefria AM; de Andrade SF
Arch Microbiol; 2022 Jul; 204(8):535. PubMed ID: 35907036
[TBL] [Abstract][Full Text] [Related]
9. Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells.
Ding WQ; Liu B; Vaught JL; Palmiter RD; Lind SE
Mol Cancer Ther; 2006 Jul; 5(7):1864-72. PubMed ID: 16891473
[TBL] [Abstract][Full Text] [Related]
10. PPARalpha signaling mediates the synergistic cytotoxicity of clioquinol and docosahexaenoic acid in human cancer cells.
Tuller ER; Brock AL; Yu H; Lou JR; Benbrook DM; Ding WQ
Biochem Pharmacol; 2009 May; 77(9):1480-6. PubMed ID: 19426685
[TBL] [Abstract][Full Text] [Related]
11. The 8-hydroxyquinoline derivative, clioquinol, is an alpha-1 adrenoceptor antagonist.
Betrie AH; Abdul-Ridha A; Hartono H; Chalmers DK; Wright CE; Scott DJ; Angus JA; Ayton S
Biochem Pharmacol; 2024 Apr; 222():116092. PubMed ID: 38408679
[TBL] [Abstract][Full Text] [Related]
12. Coordination of hydroxyquinolines to a ruthenium bis-dimethyl-phenanthroline scaffold radically improves potency for potential as antineoplastic agents.
Heidary DK; Howerton BS; Glazer EC
J Med Chem; 2014 Nov; 57(21):8936-46. PubMed ID: 25314373
[TBL] [Abstract][Full Text] [Related]
13. Development of a copper-clioquinol formulation suitable for intravenous use.
Wehbe M; Malhotra AK; Anantha M; Lo C; Dragowska WH; Dos Santos N; Bally MB
Drug Deliv Transl Res; 2018 Feb; 8(1):239-251. PubMed ID: 29247315
[TBL] [Abstract][Full Text] [Related]
14. Gluconjugates of 8-hydroxyquinolines as potential anti-cancer prodrugs.
Oliveri V; Giuffrida ML; Vecchio G; Aiello C; Viale M
Dalton Trans; 2012 Apr; 41(15):4530-5. PubMed ID: 22354329
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitization of clioquinol and zinc in human cancer cell lines.
Lu S; Ke Y; Wu C; Zhong Y; Xie C; Zhou Y; Zhou F; Yu H
BMC Cancer; 2018 Apr; 18(1):448. PubMed ID: 29678153
[TBL] [Abstract][Full Text] [Related]
16. Investigation on the pharmacological profile of antimony(III) complexes with hydroxyquinoline derivatives: anti-trypanosomal activity and cytotoxicity against human leukemia cell lines.
Reis DC; Pinto MC; Souza-Fagundes EM; Rocha LF; Pereira VR; Melo CM; Beraldo H
Biometals; 2011 Aug; 24(4):595-601. PubMed ID: 21221718
[TBL] [Abstract][Full Text] [Related]
17. Effects of 5-chloro-7-iodo-8-hydroxyquinoline (clioquinol) and nerve growth factor on DNA, RNA and protein syntheses in neonatal rat superior cervical ganglia.
Hori S; Kayanuma K; Ohtani S; Sugiura H; Kotaki H; Tsubaki T
Pharmacol Toxicol; 1988 Oct; 63(4):225-32. PubMed ID: 2461553
[TBL] [Abstract][Full Text] [Related]
18. Effect of 8-hydroxyquinoline and derivatives on human neuroblastoma SH-SY5Y cells under high glucose.
Suwanjang W; Prachayasittikul S; Prachayasittikul V
PeerJ; 2016; 4():e2389. PubMed ID: 27635352
[TBL] [Abstract][Full Text] [Related]
19. Clioquinol-zinc chelate: a candidate causative agent of subacute myelo-optic neuropathy.
Arbiser JL; Kraeft SK; van Leeuwen R; Hurwitz SJ; Selig M; Dickersin GR; Flint A; Byers HR; Chen LB
Mol Med; 1998 Oct; 4(10):665-70. PubMed ID: 9848083
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological exploitation of clioquinol-derived copper-binding apoptosis inducers triggering reactive oxygen species generation and MAPK pathway activation.
Chen HL; Chang CY; Lee HT; Lin HH; Lu PJ; Yang CN; Shiau CW; Shaw AY
Bioorg Med Chem; 2009 Oct; 17(20):7239-47. PubMed ID: 19748786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
